De novo membranous glomerulopathy in a renal transplant patient treated with FK 506. The first reported case.
We describe a case of de novo membranous glomerulopathy in the renal allograft of a diabetic patient, treated with the newer immunosuppressive agent FK 506. Twenty-two months later this patient developed nephrotic range proteinuria.